Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are
composed of a variety of pathologies with differing risks of associated malignancy. While …

In this review, we highlight adaptations in the WHO 2012 classification of papillary and
neuroendocrine breast lesions as compared with the previous 2003 version. Consensus …

Background The clinical management of nonmalignant breast papillary lesions diagnosed at
core-needle biopsy (CNB) is controversial. A meta-analysis was performed to evaluate …

In the setting of breast cancer screening, 5–9% of needle core biopsies are diagnosed as
lesions of uncertain malignant potential (B3). The management of these lesions is potentially …

Background The purpose of this study was to determine whether surgical excision of benign
solitary intraductal papillomas (BSIP) diagnosed by core needle biopsy (CNBx) without an …

Purpose: The management of benign intraductal papilloma (IDP) without atypia diagnosed
on core needle biopsy (CNB) remains controversial. This study was performed to evaluate …

Background There is no consensus regarding the management of benign papillary breast
lesions diagnosed on image-guided core needle biopsy (IGCNB). Methods This is a …

Purpose To prospectively determine the rate of malignancy after surgery in papillary lesions
initially diagnosed at ultrasound (US)-guided 11-gauge vacuum-assisted breast biopsies …

Pathologists frequently encounter non‐malignant histological findings in percutaneous core
needle biopsies (CNB s). Standards for the management of patients with lesions such as …

One-hundred-fourteen consecutive cases of breast ultrasound-guided 14-gauge needle
core biopsy (14G NCB) performed from January 2001 to June 2013 and diagnosed as non …